Reuters -- U.S. drug maker Eli Lilly (LLY.N) plans to launch 15 new products in China in the next five years, chief executive John Lechleiter said on Tuesday, while urging China to be more vigilant on intellectual property rights.
Reuters -- U.S. drug maker Eli Lilly (LLY.N) plans to launch 15 new products in China in the next five years, chief executive John Lechleiter said on Tuesday, while urging China to be more vigilant on intellectual property rights.
